Ardeparin Terminated Phase 3 Trials for Venous Thromboembolism (VTE) Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00714597Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility